TP53 and anaplastic large cell lymphoma: The sALCL, primary cutaneous ALCL, and BIA-ALCL had similar characteristics, involving constitutive activation of the STAT3 pathway, PD-L1/PD-1 immune-checkpoint expression, PD-L1 gene amplification, and TP53 deficiency (36).